Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 47


Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis.

Currie CJ, Berni E, Jenkins-Jones S, Poole CD, Ouwens M, Driessen S, de Voogd H, Butler CC, Morgan CL.

BMJ. 2014 Sep 23;349:g5493. doi: 10.1136/bmj.g5493.


The medico-legal aspects of prescribing vitamin D.

Davies JS, Poole CD, Feldschreiber P.

Br J Clin Pharmacol. 2014 Dec;78(6):1257-63. doi: 10.1111/bcp.12472. Review.


Vitamin D and falls.

Davies JS, Poole CD.

Lancet Diabetes Endocrinol. 2014 Jul;2(7):540-1. doi: 10.1016/S2213-8587(14)70125-1. No abstract available.


The short-term impact of vitamin D-based hip fracture prevention in older adults in the United Kingdom.

Poole CD, Smith JC, Davies JS.

J Endocrinol Invest. 2014 Sep;37(9):811-7. doi: 10.1007/s40618-014-0109-2. Epub 2014 Jun 24.


Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy.

Poole CD, Bannister CA, Andreasen JN, Andersen JS, Currie CJ.

Health Qual Life Outcomes. 2014 Jun 13;12:99. doi: 10.1186/1477-7525-12-99.


Vitamin D: too much of a good thing?

Davies JS, Poole CD.

Br J Gen Pract. 2014 Jan;64(618):8-9. doi: 10.3399/bjgp14X676276. No abstract available.


The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study.

Morgan CL, Puelles J, Poole CD, Currie CJ.

J Diabetes Complications. 2014 May-Jun;28(3):360-4. doi: 10.1016/j.jdiacomp.2014.01.007. Epub 2014 Jan 17.


Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study.

Morgan CL, Owens DR, Aubonnet P, Carr ES, Jenkins-Jones S, Poole CD, Currie CJ.

BMJ Open. 2013 Dec 3;3(12):e004025. doi: 10.1136/bmjopen-2013-004025.


Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?

Kern KU, Nowack W, Poole C.

Pain Pract. 2014 Feb;14(2):E42-50. doi: 10.1111/papr.12143. Epub 2013 Dec 1.


Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data.

Morgan CL, Emery P, Porter D, Reynolds A, Young A, Boyd H, Poole CD, Currie CJ.

Rheumatology (Oxford). 2014 Jan;53(1):186-94. doi: 10.1093/rheumatology/ket333. Epub 2013 Oct 18.


The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).

Holden SE, Jenkins-Jones S, Poole CD, Morgan CL, Coghill D, Currie CJ.

Child Adolesc Psychiatry Ment Health. 2013 Oct 11;7(1):34. doi: 10.1186/1753-2000-7-34.


External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.

Bannister CA, Poole CD, Jenkins-Jones S, Morgan CL, Elwyn G, Spasic I, Currie CJ.

Diabetes Care. 2014 Feb;37(2):537-45. doi: 10.2337/dc13-1159. Epub 2013 Oct 2.


Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.

Vergote IB, Garcia A, Micha J, Pippitt C, Bendell J, Spitz D, Reed N, Dark G, Fracasso PM, Ibrahim EN, Armenio VA, Duska L, Poole C, Gennigens C, Dirix LY, Leung AC, Zhao C, Soufi-Mahjoubi R, Rustin G.

J Clin Oncol. 2013 Nov 10;31(32):4060-6. doi: 10.1200/JCO.2012.45.1278. Epub 2013 Sep 30.


The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.

Wagner T, Poole C, Roth-Daniek A.

Pain Med. 2013 Aug;14(8):1202-11. doi: 10.1111/pme.12143. Epub 2013 May 24.


Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.

Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL.

J Clin Endocrinol Metab. 2013 Feb;98(2):668-77. doi: 10.1210/jc.2012-3042. Epub 2013 Jan 31.


Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study.

Poole CD, Halcox JP, Jenkins-Jones S, Carr ES, Schifflers MG, Ray KK, Currie CJ.

Clin Ther. 2013 Jan;35(1):40-51. doi: 10.1016/j.clinthera.2012.11.008. Epub 2012 Dec 13.


The impact of treatment non-compliance on mortality in people with type 1 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

J Diabetes Complications. 2013 May-Jun;27(3):219-23. doi: 10.1016/j.jdiacomp.2012.10.006. Epub 2012 Nov 13.


What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes.

Morgan CL, Poole CD, Evans M, Barnett AH, Jenkins-Jones S, Currie CJ.

J Clin Endocrinol Metab. 2012 Dec;97(12):4605-12. doi: 10.1210/jc.2012-3034. Epub 2012 Oct 17.


The impact of treatment noncompliance on mortality in people with type 2 diabetes.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, Burton CM, Evans M.

Diabetes Care. 2012 Jun;35(6):1279-84. doi: 10.2337/dc11-1277. Epub 2012 Apr 17.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk